Published on

Timothy B. Erickson and Timothy J. Meehan

Originally published in 2014. Substantially updated and clinically reviewed in 2026.

Introduction

Toxicologic urgencies may point to a specific toxidrome - a pattern of symptoms and signs that point to a particular toxin class, thus allowing for rapid identification and management of the likely intoxicant.

Poisonings represent a major cause of preventable morbidity and mortality. In 2024, US poison centers handled approximately 2.09 million human exposure cases. The urgent care clinician must recognize potentially serious exposures, initiate stabilization when necessary, contact a poison center early, and select an appropriate disposition. Clinical assessment takes precedence over attempts to identify an exact substance in the urgent care setting. [1,2]

Because the exposure may be initially asymptomatic, a normal first examination does not exclude significant toxicity. Long-acting, modified-release, and delayed-onset agents require particular caution. [2,3]

Presentation

  • Presentation can be variable.
  • Ingestion can be witnessed or unwitnessed, intentional or accidental.
  • If a patient presents with altered mental status, check their blood glucose level.
  • Exposure may also occur by inhalation, skin or eye contact, injection, or ingestion. Mixed exposures and incorrect substance identification are common barriers to diagnosis.
  • Do not assume that an intentional ingestion or a reported small dose is medically harmless. Assess for self-harm risk and arrange an emergency evaluation when intentional self-poisoning is suspected.

Triage Pearls

  • Patients with accidental or intentional ingestion can present with a constellation of signs and symptoms.
  • Generally, patients with a history of toxic ingestion or with signs and symptoms consistent with a toxidrome should be transferred to an emergency department for further evaluation.
  • Health-care providers should maintain a high index of suspicion, particularly in patients with a confounding presentation or history.
  • Immediately assess airway, breathing, circulation, mental status, temperature, oxygen saturation, and bedside glucose. Identify seizures, hypoventilation, arrhythmia, hypotension, marked agitation, severe hyperthermia, or persistent altered consciousness. Activate EMS for instability. [2,4]
  • Call Poison Help at 1-800-222-1222 for case-specific recommendations as early as possible; a poison center can help determine whether an asymptomatic, clearly identified exposure can safely be managed without ED transfer. [2]
  • Do not use an isolated normal vital-sign set or a short period of observation to clear an exposure with unknown quantity, uncertain timing, delayed toxicity, or potential for severe poisoning. [2,3]
  • The following selected substances can kill with a single ingestion:
    • Diphenoxylate-atropine
    • Calcium-channel blockers
    • Camphor
    • Clonidine
    • Colchicine
    • Opioids
    • Salicylates (methyl salicylate or aspirin)
    • Sulfonylureas
    • Tricyclic antidepressants
  • Also treat even apparently small or single-unit pediatric exposures to beta-blockers, certain antiarrhythmics, and other high-risk medications as potentially dangerous until reviewed with Poison Control. The traditional "one pill can kill" list is illustrative, not exhaustive.

History Pearls

  • Check for history of a recent ingestion. In adults who are in an altered state of consciousness or in children who either are too young to provide specific details or have an altered level of consciousness because of their ingestion, alternative sources of information ought to be considered.
  • For potential poison ingestion or exposure, check for the following:
    • Substance to which the patient was exposed
    • Timing of the exposure or ingestion
    • Amount ingested
    • Other medications and poisons available in the home that may have been ingested.
  • If necessary, send a family member or friend back to the home to collect pill bottles, including over-the-counter and herbal supplements or vitamins or other potentially ingested substances.
  • Assume the worst-case scenario until proven otherwise.
  • Ask about formulation (immediate or extended release), route, co-ingestants, alcohol or substance use, medication changes, occupational or environmental exposures, pregnancy where relevant, and symptoms since the exposure. Establish the earliest and latest plausible time of exposure. [3]
  • Have the caregiver bring the original container or a photograph of the label; do not delay emergency transport to retrieve it. Do not send an unstable patient or sole caregiver away to collect bottles.
  • For pediatric exposures, estimate the maximum accessible number of tablets or amount of liquid rather than relying only on an uncertain reported dose.

Physical Exam Pearls

  • Perform a complete physical exam.
  • Check the heart rate, respiratory rate, blood pressure, and temperature for signs of toxicity.
  • Check for potentially dose-dependent effects on pupillary size, level of consciousness, neuromuscular tone, and presence or absence of diaphoresis, which may be suggestive of specific ingestions.
  • Repeat vital signs and reassess airway protection, respiratory effort, perfusion, pupils, skin moisture, muscle tone, bowel sounds, and mental status. Look for trauma or coexisting medical illness. [2,4]
  • Normal pupils do not exclude opioid intoxication; toxidrome findings are helpful clues but are not sufficiently sensitive or specific to identify every toxin. [2,5]

Testing Pearls

  • In patients with a significant or unknown ingestion, extensive laboratory testing may be necessary, and therefore transfer to an emergency department for work-up is suggested.
  • If the patient's mental status is depressed, perform a stat bedside glucose oxidase test.
  • If the ingested substance is known or if the patient is without obvious signs of toxicity, the physician can be more selective in the choice of laboratory tests.
  • Do not delay resuscitation or transfer for laboratory tests. A bedside glucose is particularly important in any patient with altered mental status; obtain an ECG if available when dysrhythmia or cardiotoxic ingestion is suspected, without delaying EMS. [2,4]
  • In the ED, testing may include an ECG, electrolytes, blood gas, renal and hepatic tests, acetaminophen and salicylate concentrations, and targeted measurements selected according to the exposure and consultant recommendations. [3,4]
  • A routine urine drug immunoassay is qualitative and may miss fentanyl, methadone, buprenorphine, oxycodone, and other substances unless the specific analyte is included. False positives and false negatives occur, and a positive test does not establish acute toxicity, dose, route, or impairment. Treat the patient, not the screen. [5]
  • In potential acetaminophen overdose, urgent ED evaluation is necessary even when the patient feels well. Serum concentrations and the time since the start of ingestion guide acetylcysteine decisions; a concentration obtained before 4 hours cannot be plotted on the standard acute-ingestion nomogram. Repeated or unknown-time ingestions require different assessment. [3,6]
Table 1. Odors of Commonly Ingested Toxins
OdorPossible source
Bitter almondsCyanide
CarrotsCicutoxin (water hemlock)
FruityDiabetic ketoacidosis, isopropanol
GarlicOrganophosphates, arsenic, dimethyl sulfoxide (DMSO), selenium
GasolinePetroleum distillates
MothballsNaphthalene, camphor
PearsChloral hydrate
Pungent aromaticEthchlorvynol
Oil of wintergreenMethyl salicylate
Rotten eggsSulfur dioxide, hydrogen sulfide
Freshly mowed hayPhosgene

Odors are historical bedside clues, not confirmatory findings. Many exposed patients have no characteristic odor, and some odors cannot be reliably perceived. Never defer treatment or transfer on the basis of odor alone.

Diagnosis Pearls

Identification of red flags for toxicologic urgencies is important because the history of ingestion may be incomplete or absent. Suspicion for any significant or unknown toxicologic ingestion should prompt transfer to an emergency department. Commonly encountered signs and symptoms of potentially threatening toxidromes include the following (mnemonic device acronyms are included in parentheses where available):

The mnemonics below are memory aids from the original edition, not validated diagnostic rules. The presentation varies with dose, time, co-ingestion, and medical comorbidity. [2,4]

Vital Signs

  • Bradycardia (PACED) can be due to ingestion of any of the following:
    • Propranolol (beta-blockers), poppies (opiates), propoxyphene, or physostigmine
    • Anticholinesterase drugs or antiarrhythmics
    • Clonidine or calcium-channel blockers
    • Ethanol or other alcohols
    • Digoxin or other digitalis drugs
  • Tachycardia (FAST) can be due to ingestion of any of the following:
    • Freebase or other forms of cocaine, Freon
    • Anticholinergics, antihistamines, antipsychotics, amphetamines, alcohol withdrawal
    • Sympathomimetics (cocaine, caffeine, amphetamines, PCP), solvent abuse, strychnine
    • Theophylline, tricyclic antidepressants, thyroid hormones
  • Hypothermia (COOLS) can be due to ingestion of any of the following:
    • Carbon monoxide
    • Opioids
    • Oral hypoglycemics, insulin
    • Liquor (alcohols)
    • Sedative-hypnotics
  • Hyperthermia may reflect sympathomimetic, anticholinergic, or serotonergic toxicity, as well as severe withdrawal or a non-toxicologic emergency. Marked temperature elevation requires immediate EMS transfer and active supportive measures. [2,4]
  • Hypotension (CRASH) can be due to ingestion of any of the following:
    • Clonidine or calcium-channel blockers
    • Rodenticides (containing arsenic, cyanide)
    • Antidepressants, aminophylline, antihypertensives
    • Sedative-hypnotics
    • Heroin or other opiates
  • Hypertension (CT SCAN) can be associated with:
    • Cocaine
    • Thyroid supplements
    • Sympathomimetics
    • Caffeine
    • Anticholinergics, amphetamines
    • Nicotine
  • Tachypnea (PANT) can be due to ingestion of any of the following:
    • PCP, paraquat, pneumonitis, phosgene
    • Acetylsalicylic acid or other salicylates
    • Noncardiogenic pulmonary edema, nerve agents
    • Toxin-induced metabolic acidosis
  • Bradypnea (SLOW) is associated with sedative-hypnotics, alcohols, and opioids; respiratory rate and tidal volume should be assessed together. [2,4]

Pupil Size

  • Miosis (COPS)
    • Cholinergics, clonidine, carbamates
    • Opiates, organophosphates
    • Phenothiazines (antipsychotics), pilocarpine, pontine hemorrhage
    • Sedative-hypnotics
  • Mydriasis (SAW)
    • Sympathomimetics
    • Anticholinergics
    • Withdrawal

Effects on the Skin

  • Diaphoretic skin (SOAP)
    • Sympathomimetics
    • Organophosphates
    • Acetylsalicylic acid or other salicylates
    • Phencyclidine
  • Dry skin
    • Antihistamines, anticholinergics
    • Barbiturates and other sedative-hypnotics
    • Snakes and spiders
  • Flushing or redness
    • Anticholinergics, niacin
    • Boric acid
    • Carbon monoxide (rare)
    • Cyanide (rare)
  • Cyanosis
    • Ergotamine
    • Nitrates
    • Nitrites
    • Aniline dyes
    • Phenazopyridine
    • Dapsone
    • Any agent that causes hypoxemia, hypotension, or methemoglobinemia
  • Acneiform rash
    • Bromides
    • Chlorinated aromatic hydrocarbons

Toxidromes

Cholinergic Toxidrome

  • Muscarinic (DUMBBELLS)
    • Diarrhea, diaphoresis
    • Urination (excess)
    • Miosis
    • Bradycardia
    • Bronchorrhea
    • Emesis
    • Lacrimation
    • Lethargy
    • Salivation (excess)
  • Nicotinic effects may include weakness, fasciculations, tachycardia, and seizures; neuromuscular respiratory failure is a major danger. [4]

Anticholinergic Toxidrome

  • Hyperthermia
  • Flushing
  • Dry skin
  • Dilated pupils
  • Delirium, hallucinations
  • Tachycardia
  • Urinary retention

Opioid Toxidrome

  • Miosis
  • Hypoventilation
  • Depressed mental status or coma
  • The immediate threat in opioid poisoning is inadequate ventilation. Miosis may be absent and other substances may contribute to sedation. [2,4]

Opioid Withdrawal

  • Diarrhea
  • Mydriasis
  • Gooseflesh
  • Tachycardia
  • Watery eyes
  • Yawning
  • Abdominal cramps
  • Diaphoresis
  • Opioid withdrawal is generally not characterized by seizures or hallucinations; consider alcohol or benzodiazepine withdrawal, intoxication, or another diagnosis if these occur. [4]

Additional Dangerous Patterns

  • Serotonin toxicity: agitation, diaphoresis, hyperreflexia, clonus, and hyperthermia, especially after a serotonergic medication exposure. [4]
  • Sympathomimetic toxicity: agitation, tachycardia, hypertension, diaphoresis, mydriasis, and possible hyperthermia or seizures. [4]
  • Sodium-channel blocker toxicity (eg, tricyclic antidepressants): altered consciousness, seizures, hypotension, and QRS widening; prompt ED management is required. [4]

Treatment Pearls

  • Generally, most patients who present with a history of an ingestion should be transferred to an emergency department unless the ingestion is known to be nontoxic and the health-care provider is absolutely sure about the time and amount of the ingestion.
  • The cornerstone of treatment of patients with a suspected overdose is supportive care, with particular attention to the ABCs: airway, breathing, and circulation.
  • Ipecac is no longer recommended in pediatric ingestions in the home or urgent care setting.
  • Gastrointestinal decontamination, including treatment with activated charcoal, may be performed in an emergency department, but it is not typically appropriate in urgent care practice.
  • Call EMS immediately for airway compromise, hypoventilation, unstable vital signs, seizure, significant agitation or hyperthermia, suspected serious cardiotoxicity, or intentional overdose. Provide oxygen, airway positioning, and bag-mask ventilation as indicated by clinical findings and local resuscitation protocols. Do not delay ventilation while preparing an antidote. [2,4,7]
  • When hypoglycemia is documented, correct it promptly using oral glucose only if the patient can safely swallow; otherwise use age-appropriate parenteral dextrose per local protocol, or emergency glucagon when appropriate and available. Avoid a universal D50 bolus recommendation for children. [4]
  • For suspected opioid-induced respiratory depression, support ventilation and administer naloxone promptly. A commonly stocked, FDA-labeled naloxone 4-mg nasal spray uses one device into a nostril; repeat with a new device after 2 to 3 minutes if breathing does not improve or respiratory depression recurs. Call EMS and continue monitoring; naloxone may wear off before the opioid. Other products and clinician doses follow their specific labeling and local protocol. [7,8]
  • Do not induce vomiting. Do not administer activated charcoal routinely in urgent care, particularly when the airway is unprotected. Decontamination, antidotes such as acetylcysteine, and other advanced therapies are generally ED/hospital or poison-center-directed interventions. [2,3,4,9]
  • For chemical exposures, remove the patient from the source using staff protection and available local hazardous-materials protocols. Promptly remove contaminated clothing and begin appropriate water irrigation of skin or eyes when indicated, while arranging poison-center guidance and transfer for significant exposure. [2]
  • Antidote choice and advanced interventions for calcium-channel blocker, beta-blocker, organophosphate, salicylate, cyanide, and tricyclic antidepressant poisonings require emergency-level monitoring and toxicology consultation. [4]

Disposition Pearls

Disposition of a patient with poisoning is not always clear and depends on many factors.

  • It is important to assess the actual clinical condition as well as potential toxicity of the purported ingestion and the social situation into which the child will be discharged.
  • A patient who ingested a potentially dangerous toxin that requires antidotal therapy, who manifests mild to moderate symptoms, or who has an unsafe home environment may benefit from inpatient admission and observation.
  • Asymptomatic patients can still require prolonged evaluation for delayed toxicity. A fixed 6-to-8-hour observation period is not sufficient for every substance, preparation, or dose. Determine the observation window with Poison Control or the ED. [2,3]
  • Patients with a significant or uncertain ingestion, persistent symptoms, abnormal ECG, co-ingestion, suicidal intent, or lack of reliable supervision should generally be transferred to an ED. An intentional self-poisoning requires an appropriate suicide-risk assessment once medically stable. [2,3]
  • An asymptomatic patient with a verified low-risk exposure may be considered for discharge only after a poison-center recommendation or a defensible, substance-specific protocol, a reassuring examination, clear return instructions, and reliable supervision. Document the advice and the basis for disposition. [2]
  • Poison prevention education should be presented to caregivers during any pediatric poisoning encounter, regardless of admission or discharge from an emergency department. In cases of adolescents and adults with recreational drug use or abuse, admission to substance abuse rehabilitation programs should be recommended. Suicidal adolescents and children should be referred for psychiatric treatment after they are medically stabilized.
  • Offer nonjudgmental substance-use assessment, overdose-prevention education, and access to naloxone or treatment referral when relevant; coordinate mental-health evaluation for intentional self-harm. [7,8]

Medicolegal Pearls

  • Patients with ingestions should generally be transferred to an emergency department. However, if the patient has a clear and corroborated history of nontoxic substance ingestion, they may be appropriate for urgent care evaluation.
  • Urgent care providers should be familiar with various toxidromes so that the appropriate differential diagnoses are considered in patients presenting with potential ingestions.
  • Because methadone has a much longer half-life than naloxone, patients who are given naloxone after methadone ingestion may require observation for an extended period of time.
  • Document the exposure history, source of information, vital signs and serial reassessments, bedside results, poison-center advice and case number when supplied, treatments, informed discussions, safety assessment, and the reason for transfer or discharge. [2]
  • Use EMS rather than private-vehicle transport for patients at risk of deterioration. Do not delay transfer for nonessential testing, charcoal, or uncertain ingestion history. [2,4]
  • Always consider unintended ingestion, medication error, and nonaccidental exposure when appropriate; document objective findings without unsupported accusations. [2]

References

Updated References Cited in the 2026 Revision

[1] Beuhler MC, Feldman R, Gummin DD, et al. 2024 Annual Report of the National Poison Data System (NPDS) from America's Poison Centers: 42nd Annual Report. Clin Toxicol (Phila). 2025;63(12):1029-1280. doi:10.1080/15563650.2025.2571299.

[2] Poison Control. First aid guidelines; contact Poison Help (1-800-222-1222). Accessed November 5, 2026. https://www.poison.org/first-aid-for-poisonings

[3] Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open. 2023;6(8):e2327739. doi:10.1001/jamanetworkopen.2023.27739.

[4] Lavonas EJ, Akpunonu PD, Arens AM, et al. 2023 American Heart Association focused update on the management of patients with cardiac arrest or life-threatening toxicity due to poisoning. Circulation. 2023;148:e149-e184. doi:10.1161/CIR.0000000000001161.

[5] Stolbach AI, Connors NJ, Nelson LS, Kulig K. ACMT position statement: interpretation of urine opiate and opioid tests. J Med Toxicol. 2022;18:176-179. doi:10.1007/s13181-021-00864-1.

[6] American College of Medical Toxicology. ACMT practice statement: duration of intravenous acetylcysteine therapy following acetaminophen overdose (2026 update). January 26, 2026. https://www.acmt.net/news/acmt-practice-statement-duration-of-intravenous-acetylcysteine-therapy-following-acetaminophen-overdose-2026-update/

[7] American Heart Association. 2025 American Heart Association guidelines for CPR and emergency cardiovascular care: adult and pediatric special circumstances of resuscitation. Circulation. 2025. doi:10.1161/CIR.0000000000001380.

[8] US Food and Drug Administration. Naloxone access can save a life during an opioid overdose. Updated 2026. https://www.fda.gov/consumers/consumer-updates/access-naloxone-can-save-life-during-opioid-overdose

[9] American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position paper: single-dose activated charcoal. Clin Toxicol. 2005;43:61-87.

Selected References Retained From the Original Edition

Albertson TE, Owen KP, Sutter ME, Chan AL. Gastrointestinal decontamination in the acutely poisoned patient. Int J Emerg Med. 2011;4:65.

American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists. Position statement and practice guidelines on the use of multidose activated charcoal in the treatment of acute poisoning. Clin Toxicol. 1999;37:731-751.

Baumann BM, Patterson RA, Parone DA, et al. Use and efficacy of nebulized naloxone in patients with suspected opioid intoxication. Am J Emerg Med. 2013;31:585-588.

Bond GR. Home syrup of ipecac use does not reduce emergency department use or improve outcome. Pediatrics. 2003;112:1061-1064.

Bosse GM, Matyunas NJ. Delayed toxidromes. J Emerg Med. 1999;17:679-690.

Bronstein AC, Spyker DA, Cantilena LR Jr, et al. 2011 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol (Phila). 2012;50:911-1164.

Chyka PA, Seger D, Krenzelok EP, Vale JA; American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. Position paper: single-dose activated charcoal. Clin Toxicol. 2005;43:61-87.

Eldridge DL, Van Eyk J, Kornegay C. Pediatric toxicology. Emerg Med Clin North Am. 2007;25:283-308.

Erickson T, Thompson T, Lu J. The approach to the patient with an unknown overdose. Emerg Med Clin North Am. 2007;25:249-281.

Meehan TJ, Bryant SM, Aks SE. Drugs of abuse: the highs and lows of altered mental states in the emergency department. Emerg Med Clin North Am. 2010;28:663-682.

Michael JB, Sztajnkrycer MD. Deadly pediatric poisons: nine common agents that kill at low doses. Emerg Med Clin North Am. 2004;22:1019-1050.

Schumann H, Erickson T, Thompson TM, et al. Deadly fentanyl epidemic in Chicago and surrounding Cook County, Illinois. Clin Toxicol (Phila). 2008;46:501-506.

Textbook of Urgent Care Medicine, Chapter 58
Log In